“The Federal Program That Keeps Insulin Prices High”
Middlemen pocket discounts while forcing patients, employers and Medicare to pay more.
“Trump order on drug prices restricts helpful program”
Congress should protect a program that helps provide medications to patients most in need.
“Trump 340B order targets clinics serving the poor”
Trump 340B order targets clinics serving the poor
“Trump issues drug pricing executive orders on 340B, outpatient drug pay”
President Donald Trump on Friday announced four executive orders to advance policies forcing community health centers that receive 340B drug
IN CASE YOU MISSED IT: New Study Finds Hospitals Charge Nearly Two Times More Than Physician Offices for Same Cancer Treatments
WASHINGTON – New research from the Employee Benefit Research Institute (EBRI) has concluded that payments from private third-party payers for infused cancer medicines are,
IN CASE YOU MISSED IT: New GAO Report Finds Oversight Lacking For 340B Hospitals
A new report from the Government Accountability Office (GAO) has concluded increased oversight is needed to ensure nongovernmental hospitals meet 340B eligibility
“PBM-Owned Specialty Pharmacies Expand Their Role In – and Profits From – the 340B Program”
Last week, I documented that nearly half of U.S. pharmacies now participate in the 340B Drug Pricing Program. Below, we
“Appeals court upholds nearly 30% payment cut to 340B hospitals”
A federal appeals court has ruled the Trump administration can install nearly 30% cuts to the 340B drug discount program.
“Congress Has no Clue About What’s Driving up Drug Prices”
A coalition of think tanks and health care organizations – dubbed Lower Drug Prices Now – just launched a campaign
“Hospitals Are Gaming the 340B Drug Program”
The COVID-19 crisis has been a brutal lesson on the limitations of government action and imagination. The response, thus far,